benefits of glp 1 drugs The expanding GLP-1 medicines: Cell Reports Medicine The GLP-1 Agonists and Obesity:

Glucagon-like peptide 1 (GLP1) receptor agonists reduce the rate of major adverse cardiovascular events in people with type 2 diabetes mellitus

Ultrasound assessments could improve risk stratification for perioperative management

Understand causes, benefits, and practical insights to support better health and informed decisions.

Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins